GLP Watchdog
Brightmeds logo

Brightmeds Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.4/10

Best for: knowing which pharmacy fills the vial — it names Beaker Pharmacy

8.4
★★★★☆4.2/5

What Brightmeds does best is charge less than most of the register.

$100/mo
Same price at every dose

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

In the price

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Compounded semaglutide opens at $189/mo, with tirzepatide at $289/mo, priced flat whatever the dose, but what renewal costs later is not published until the intake quiz is done. A single membership spans longevity peptides (sermorelin, NAD+, glutathione), TRT aimed at men, and GLP-1 weight loss. Both modalities are stocked, compounded drugs with microdosing protocols included and branded Zepbound in pens and vials, a mix rarely seen. 47 states are served.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $100/moPrice after intakeFlat across dosesIncludes medication + consult47 statesPharmacy namedNo FDA letter on record

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Vetted alternatives to Brightmeds

7.9/ 10
Verified partner

Oak

Best for: semaglutide at $119/month, 37% under the register median

★★★★☆4/5

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →
6.5/ 10
Verified partner

Direct Meds

Best for: compounded semaglutide at $249/month

★★★☆☆3.3/5

Editorial score · methodology

$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
8.8/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% under the register median

★★★★☆4.4/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
Brightmeds logo
4.2 / 5
Our editorial rating
Visit Brightmeds →

from $100/mo · no insurance needed

Brightmeds at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide, Zepbound
Starting price
$100/mo (/products verbatim: '$100 Brightmeds doctor consult fee — Prescription sent to LillyDirect® or your preferred local p...)
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping · Labs
Availability
47 states
FDA status
No FDA warning letter on record

How Brightmeds scores

Six columns, each one computed from something Brightmeds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.

Value25%

10.0/10

$100/month is 63% below the register median of $267 for compounded tirzepatide.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

3.0/10

On the seller's own pages, no price appears until the medical intake is finished.

Trust & Safety15%

7.5/10

names its dispensing pharmacy; withholds price until after the intake; publishes its state list. Our verification confidence is high.

Accessibility10%

9.5/10

Publishes coverage in 47 of 50 states.

Support10%

8.5/10

The price covers medication, consult, shipping, labs.

6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →

What we checked on Brightmeds

Last checked July 2026
  • Re-read the price on file across 4 dose or plan tiers
  • Checked state coverage: all 50
  • Established what the monthly figure covers, and what it leaves out
  • Confirmed which compounding pharmacy fills the order, and its accreditation
  • Searched our FDA enforcement register for this operator

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.

What signing up with Brightmeds involves

Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.

  1. 1Brightmeds does not show a price until you have worked through its medical questionnaire. Budget for the fact that you cannot compare it against anything until you have handed over health information.
  2. 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
  3. 3A prescription is dispensed by Beaker Pharmacy, which Brightmeds names publicly. Most sellers in this register do not.
  4. 4The monthly price is recorded as covering medication, consult, shipping, labs.
Price shown only after intake
  • Cheapest standing monthly prices on record: semaglutide $189, tirzepatide $100. Membership fees, first-month rates and insured copays are excluded from those figures.
  • Coverage is published for 47 of 50 states.
  • The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.

GLP-1 medications Brightmeds offers

Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.

SemaglutideTirzepatideWegovyOzempicMounjaroZepboundRybelsus

Peptides Brightmeds offers

Brightmeds sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.

DropletGlutathioneAntioxidant infusionsDropletNAD+Energy & cellular agingSyringeSermorelinOwn growth-hormone output

Pricing

Prices re-verified

all doses (flat-price, 1-month plan)Compounded
$189/mo
semaglutide

'Starting at $189' is the only published sema price (1-month plan per on-page comparison chart); ongoing/renewal price NOT published anywhere on public pages as of 2026-07-14 — the '$333/mo therafter' card verified 2026-06-06 has been removed. 'Save $50 on our First Order' banner active.

all doses (flat-price, 1-month plan)Compounded
$289/mo
tirzepatide

'Starting at $289' shown on the sema lander card and in the tirz lander's pricing-comparison image ('Tirzepatide (1-Month) $289 — Best Price! 1-Month Plan'); the tirz lander TEXT now contains no dollar prices at all — both the old '$249/mo' hero and '$397/mo therafter' card are gone. Ongoing price quiz-gated = not published.

TRT $75/week (~$325/mo equivalent), free baseline labsCompounded · oral
$325/mo
testosterone (trt)

Unchanged — page title verbatim 'Brightmeds: Choose Your TRT Goal: $75 Per Week, Free Labs'. TRT side-effect disclosures now also cover Enclomiphene and Anastrozole (new adjunct meds).

$100 consult fee; drug billed separately by pharmacyCompounded
$100/mo
tirzepatide (brand zepbound)

/products verbatim: '$100 Brightmeds doctor consult fee — Prescription sent to LillyDirect® or your preferred local pharmacy — You'll pay the pharmacy directly (price may vary by pharmacy)'; vials 'Medication cost is billed separately by LillyDirect®'. Drug price not published by Brightmeds.

Check the price yourself before you pay

Every figure here was read off Brightmeds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See Brightmeds pricing →

Brightmeds compounding-pharmacy partners

Each partner below is a 503A or 503B pharmacy that Brightmeds routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.

Compare every compounding pharmacy we’ve reviewed →

In its favor

  • Tirzepatide at $100 a month, 63% below the $267 median for the same drug and form across this register
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping, labs
  • Coverage is published for 47 states
  • Names 2 dispensing pharmacies, which most sellers in this register do not do
  • No FDA warning letter matched this operator when we searched our enforcement register

Against it

  • No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What Brightmeds charges

The standing price at Brightmeds is $100/month, unchanged as the dose goes up. That sits at the affordable end of what we track. Flat dose pricing matters more than it reads: on a tiered plan the bill grows as the dose does, which means the figure that persuaded you to sign up is not the figure you end up living with.

  • Compounded semaglutide — $189/month
  • Compounded tirzepatide — $289/month
  • Oral testosterone (trt) — $325/month
  • Compounded tirzepatide (brand zepbound) — $100/month

Across the GLP-1 providers in our register the median standing price is about $169/month, so Brightmeds is genuinely under the middle rather than merely advertising that it is.

CoreAge Rx dispenses semaglutide and tirzepatide from $99/month, which makes it the honest comparison to run before committing here.

What Brightmeds dispenses

Brightmeds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.

A needle-free oral option is genuinely uncommon and is the reason some readers will look at Brightmeds at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.

What we could verify

On the record: it treats patients in all 50 states, it dispenses through an accredited compounding pharmacy, and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.

Who should look elsewhere

  • You want the FDA-approved pen specifically. Nothing here is the approved finished product.
  • You need to bill insurance. Like most of this market, this is cash-pay.

It fits if

  • the lowest standing monthly cost is what you are solving for
  • you want the price to stop moving as your dose climbs
  • injections are the thing keeping you from starting
  • you need access regardless of where you live

Our read

Brightmeds competes on price and does it without an obvious sacrifice elsewhere: $100/month, no warning letter on file, and access that is not unusually restricted.

The Bottom Line

What Brightmeds does best is charge less than most of the register.

Score: 8.4/10Best for: knowing which pharmacy fills the vial — it names Beaker PharmacyFrom: $100/mo

Before you pay Brightmeds

Starting at $100/month. Check today's price, then book the free consultation.

Visit Brightmeds →

Where Brightmeds is the wrong choice

No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider Found.
  • If you want a human checking in, not just a prescription, consider Oak.
See all alternatives to Brightmeds →

Frequently Asked Questions

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this Brightmeds review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of August 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Brightmeds's current pricing

Plans start at $100/month. The free consultation is where you learn whether you qualify, and what it costs today.

Visit Brightmeds →